At a glance
ClinicalIndex Comparison RecordN/ACompleted· 209 enrolled
Drug / intervention
EVPdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Multi-Centre Study to Evaluate the Safety of Use of Electronic Vapour Products for Two Years
In Brief
A clinical study evaluating EVP for Healthy Volunteers. Completed, enrolled 209 participants across 2 sites.
Detailed Summary
Electronic Vapour Products (EVPs) is a relatively new class of consumer products that are otherwise known as electronic cigarettes devices/systems. These may look like conventional cigarettes but do not contain tobacco. The 'vapour' produced by such devices typically consists of humectants (propylene glycol or glycerol), nicotine, water, and flavours. This trial is to evaluate the safety and tolerability of an EVP over two years.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsHealthy Volunteers
CountriesUnited Kingdom
Collaborators--
Timeline
N/ACompletedFinished
2014201520162017201820192020202120222023202420252026
Enrollment StartMay 2014
First PostedMay 2014
Primary CompletionDec 2016
TodayJul 2026
First PostedMay 21, 2014
Enrollment StartMay 1, 2014
Primary CompletionDec 29, 2016
TodayJul 2, 2026
Enrollment to primary: 2.7 yearsPosted 12.1 years ago
Interventions
EVPdevice